Globus Medical Inc. (NYSE: GMED)

MarketGrader Overall Grade:
MarketGrader Sentiment Score:

As the global population ages, degenerative spine and musculoskeletal disorders are becoming increasingly common. In many cases, treatment requires surgical intervention. Since its founding in 2003, Globus Medical has focused on addressing the needs of this growing patient population through spinal implants and advanced surgical solutions.

In the 12 months ended last September, the company generated $2.77 billion in medical device sales, nearly three times the level reported three years earlier. Over the same period, profits surged 173% to $424 million.

This sustained expansion supports the company’s grade of A in our Growth category. Combined with composite grades of A- in Value, B+ in Profitability, and A- in Cash Flow, these fundamentals translate into a MarketGrader Overall Grade of 77.4. Globus Medical ranks first among 176 U.S.-listed companies in the Medical Specialties industry in MarketGrader, earning it our designation as Fundamental Idea of the Week.

Additional highlights include:

  • Quarterly revenue increased 23% in the most recent quarter compared with the prior year, while quarterly operating income rose nearly 75% over the same period.
  • Gross margins expanded from 53% to 61% over the last 12 months, and operating margins more than doubled from 7.3% in 2024 to 16.2% through last September.
  • Free cash flow has grown 391% over the past three years, despite a doubling of capital expenditures during that time.
  • Total debt stands at $120 million, representing just 2.7% of total capital.

The company’s strong fundamentals are reinforced by a Sentiment score of 9.0 out of 10. This score is derived from four indicators designed to measure short-term demand for the stock and overall investor sentiment. It complements our fundamental analysis by helping investors identify high quality companies that are also supported by favorable market dynamics.

Globus Medical also appears on several of our idea lists, including Best Growth Stocks, Best Large Caps, and Improving Earnings Guidance Stocks, and is currently a constituent of seven MarketGrader Indexes.

MarketGrader generates hundreds of unique ideas like this one every week across global markets. Subscribe to MarketGrader Advanced today for unlimited access.

Share this post:

Achieve higher returns
with smarter stock selection

Identify the best companies in the world using MarketGrader’s time-tested, objective ratings on 41,000+ stocks.

Browse by Topic:

Two Solutions, One Goal

Smarter Investing

Two Solutions, One Goal

Smarter Investing

Professional

Get in touch

For all other inquiries, please reach out at: